Clinical Trials Directory

Trials / Completed

CompletedNCT03255486

Identification and Evaluation of Biomarkers of Resistance to Neoadjuvant Chemotherapy (IDEA SEIN)

Identification and Evaluation of Biomarkers of Resistance to Neoadjuvant Chemotherapy and Establishment of Preclinical Models of Resistance in Locally Advanced Breast Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
164 (actual)
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Biomarkers of resistance to neoadjuvant chemotherapy in locally advanced breast cancer

Detailed description

Identification and evaluation of biomarkers of resistance to neoadjuvant chemotherapy and establishment of preclinical models of resistance in locally advanced breast cancer

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood sampleBlood samples will be taken by venipuncture during the initial assessment (4 tubes of 5 ml at diagnosis and 3 tubes of 5 ml to the following) These blood tests will be repeated after the first course, at the end of neoadjuvant chemotherapy and after surgery and will be carried out jointly to levies motivated by the balance sheet or the treatment of CS to avoid additional puncture. These samples will allow us to study the profiles of circulating tumor DNA, and miRNA tumor proteins (proteomics study).

Timeline

Start date
2013-07-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2017-08-21
Last updated
2017-08-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03255486. Inclusion in this directory is not an endorsement.